| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Sep'18 | Jun'18 |
|---|---|---|---|---|---|---|
Operating Expenses: | ||||||
Research and development | ||||||
51,804 | 48,798 | 41,801 | 28,172 | 0 | 0 | 0 |
General and administrative | ||||||
22,982 | 17,005 | 10,970 | 7,477 | 0 | 0 | 0 |
Operating loss | ||||||
-74,786 | -65,803 | -52,771 | -35,649 | 0 | 0 | 0 |
Change in fair value of derivative liabilities | ||||||
- | - | 0 | 0 | - | 0 | 0 |
Other income | ||||||
0 | - | - | - | 0 | - | - |
Interest income | ||||||
2,758 | 2,615 | 2,225 | 1,458 | 0 | 0 | 0 |
Interest expense | ||||||
- | - | 0 | 0 | - | 0 | 0 |
Total other income | ||||||
2,968 | 2,615 | 2,225 | 1,458 | 0 | 0 | 0 |
Net loss | ||||||
-71,818 | -63,188 | -50,546 | -34,191 | 0 | 0 | 0 |
Net loss per share | ||||||
Basic and Diluted | ||||||
-0.56 | 0.71 | -0.62 | -0.58 | -1.73 | -0.99 | -0.19 |
Weighted average shares outstanding: | ||||||
Basic and Diluted | ||||||
33,267 | 49,162 | 32,864 | 26,212 | 5,740 | 5,244 | 20,326 |